Support program for advanced liver cancer
Part of Cancer, Digestive system clinical trials.
This trial tests whether a behavioral program delivered through your smartphone can improve survival and quality of life for people whose liver cancer cannot be surgically removed. You and a caregiver will use WeChat to stay connected and complete tasks from home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with primary liver cancer that cannot be removed with surgery.
- You are between 18 and 75 years old.
- You are generally able to care for yourself (you may need some help).
- Your liver function is moderately good (not the worst level).
- You and a caregiver must be comfortable using a smartphone and WeChat to complete questionnaires and tasks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests new treatment plans for people with advanced liver cancer that has worsened after initial therapy. The goal is to find more effective, personalized options based on how your cancer responds.
This study tests a smartphone-based program to help people with advanced lung cancer manage their symptoms and daily life. The program uses WhatsApp or WeChat to provide support and aims to improve quality of life.
This trial tests whether using a smartphone app to regularly report your symptoms can help you and your doctor manage side effects better during immunotherapy treatment for liver cancer. It is a study where you would be randomly assigned to either use the app or receive usual care.
This study is testing whether combining targeted therapy with immunotherapy (or using two immunotherapies together) can help people with liver cancer that cannot be surgically removed. The goal is to understand how well these treatments work and how they affect biomarkers (signals in your body that show treatment response).
This trial tests a combination of two treatments for advanced liver cancer that cannot be removed by surgery. One treatment delivers chemotherapy directly to the tumor, and the other uses tiny beads to block the tumor's blood supply. This approach may help shrink tumors and slow the cancer's growth.
This trial tests a “whole process follow-up” care plan, using a smartphone, to support people with non-small cell lung cancer from diagnosis through treatment and follow-up. It may help you manage care steps more smoothly if you’re not a candidate for curative (radical) treatment or don’t want surgery.
Hear when a new Primary Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.